ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,713.64
      1.70%
      US Tech 100
      19,284.00
      -0.26%
      Dow Jones
      42,025.19
      1.26%
      Brent Oil
      74.01
      -0.42%
      Bitcoin
      63,488.00
      0.86%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. AMEX

      6. Synthetic Biologics Inc (SYN) Quote

      Synthetic Biologics Inc

      Synthetic Biologics Inc (SYN)

      Synergia Energy Ltd
      Synergia Energy Ltd
      1.02
      0.00
      (0.00%)
      Closed September 19 4:00PM
      Delayed by 15 minutes
      1.02
      0.00
      ( 0.00% )
      Pre Market: 8:00PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      1.02
      Bid
      -
      Ask
      -
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Market Cap
      17.384M
      Previous Close
      1.02
      Open
      -
      Last Trade
      Last Trade Time
      -
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      -
      Shares Outstanding
      17,043,000
      Dividend Yield
      -
      PE Ratio
      -3.52
      Earnings Per Share (EPS)
      -1.08
      Revenue
      -
      Net Profit
      -18.35M

      About Synthetic Biologics Inc

      Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbio... Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Business Services
      Website
      www.syntheticbiologics.com
      Headquarters
      Rockville, Maryland, USA
      Founded
      1993

      Ask ADVFN Intelligence (AI)

      SYN Latest News

      More News

      Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference

      Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference PR Newswire ROCKVILLE, Md., Feb. 9, 2022 ROCKVILLE, Md., Feb. 9, 2022 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE...

      February 09 2022
      PR Newswire (US)

      Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA

      Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA Follows recent announcement of planned acquisition of VCN Biosciences...

      February 08 2022
      PR Newswire (US)

      Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022

      Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022 PR Newswire ROCKVILLE, Md., Jan. 26, 2022 ROCKVILLE, Md., Jan. 26, 2022 /PRNewswire/ -- Synthetic...

      January 26 2022
      PR Newswire (US)

      Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors

      Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors Lead drug candidate...

      December 14 2021
      PR Newswire (US)

      Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

      Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET Initiated a Phase 1 Multiple Ascending Dose Clinical...

      November 03 2021
      PR Newswire (US)

      Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021

      Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021 -- Conference Call Scheduled for Wednesday, November 3, 2021 at 4:30 p.m. ET...

      October 26 2021
      PR Newswire (US)

      Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase

      Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase Topline Data Readout Expected in Q2 2022 Phase 1 Clinical...

      October 21 2021
      PR Newswire (US)

      Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

      Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum The Company Encourages All Shareholders of Record Who Have Not Yet Voted to Do So by...

      October 06 2021
      PR Newswire (US)

      Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

      Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum PR Newswire ROCKVILLE, Md., Sept. 21, 2021 ROCKVILLE, Md., Sept. 21, 2021 /PRNewswire/...

      September 21 2021
      PR Newswire (US)

      Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

      Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET Phase 1 Single-Ascending Dose Clinical Trial of...

      August 05 2021
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000CS
      40000000CS
      120000000CS
      260000000CS
      520000000CS
      1560000000CS
      2600000000CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      BATLBattalion Oil Corporation
      $ 6.46
      (119.73%)
      		73.31k
      IRVHGlobal X Interest Rate Volatility and Inflation Hedge ETF
      $ 34.09
      (58.96%)
      		66
      PWPower REIT
      $ 1.20
      (16.50%)
      		15
      AEONAEON Biopharma Inc
      $ 0.7325
      (9.49%)
      		4.73k
      PEJInvesco Leisure and Entertainment ETF
      $ 51.74
      (8.61%)
      		1
      SGNSigning Day Sports Inc
      $ 0.3762
      (-29.02%)
      		866.04k
      ATCHAtlasClear Holdings Inc
      $ 0.1611
      (-11.29%)
      		2.07k
      MTNBMatinas Biopharma Holdings Inc
      $ 3.39
      (-10.08%)
      		6
      HCWCHealthy Choice Wellness Corp
      $ 2.75
      (-7.41%)
      		24.3k
      ETHDProshares Ultrashort Ether ETF
      $ 60.00
      (-6.60%)
      		467
      SOXLDirexion Daily Semiconductor Bull 3X Shares
      $ 34.20
      (-2.62%)
      		1.81M
      SOXSDirexion Daily Semiconductor Bear 3X Shares New
      $ 22.34
      (2.76%)
      		1.38M
      SGNSigning Day Sports Inc
      $ 0.3762
      (-29.02%)
      		866.04k
      TZADirexion Daily Small Cap Bear 3X Share New
      $ 13.31
      (0.99%)
      		331.04k
      NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
      $ 5.075
      (1.81%)
      		325.31k

      Discussion

      View Full Feed
      $5.95akadawson-m $5.95akadawson-m 7 minutes ago
      Look in your email box. Gulp. Company is pushing for a reverse split 1:30. Game over yet again.
      FCEL
      Methinks Methinks 8 minutes ago
      https://www.bbc.co.uk/news/articles/cd7x5q39z77o
      Come on - protect the kids! Use Wave.
      Methinks Methinks 9 minutes ago
      https://www.mishcon.com/news/mishcon-de-reya-becomes-the-first-law-firm-to-be-an-ncsc-cyber-incident-response-assured-service-provider
      But are they dealing with Wave?
      DP1011 DP1011 10 minutes ago
      Massive sell off, oh the humanity..🫣🧐
      PHIL
      TrendTrade2016 TrendTrade2016 12 minutes ago
      BNZI...LETS SEE IT HOLD 5.00 INTO REG PRE TRADING
      BNZI
      Methinks Methinks 12 minutes ago
      https://securityboulevard.com/2024/09/the-supply-chain-conspiracy-cyber-attacks-behind-the-lebanon-explosions/
      Could these attacks have taken place because there is a fundamental change about to happen in the cyber industry?
      Ribo Ribo 12 minutes ago
      First of 2 updates.
      https://x.com/IDVVcorp/status/1836432708312207474
      IDVV
      TrendTrade2016 TrendTrade2016 14 minutes ago
      FAKE BID LIKE ASII BEFORE IT GOT DUMPED TO .0009 THIS IS NEXT AND YOU WILL NEVER SEE IT TRADE AGAIN FOR ANOTHER YEAR UNTIL NEXT FAKE PLOT
      ASII
      ShawnP123 ShawnP123 16 minutes ago
      Doesn't look good for today. Looks like it's gonna lose a lot of yesterday's gain. I still don't feel this stock will get above 120 for some time. Maybe in May or June of 2025. Market isn't going to be happy with just beating estimates. They still expect huge estimate beats which isn't realistic. Mo
      NVDA
      tw0122 tw0122 18 minutes ago
      GDHG and BNZI
      BNZI GDHG
      tw0122 tw0122 19 minutes ago
      Let’s get going $4.40s +!73%
      GDHG
      Horseb4CarT Horseb4CarT 22 minutes ago
      DCVax costs of patient care for many cancers should be significantly less than the overall costs of patient care for current cancer treatments.

      The current cancer treatments are costly for the actual treatment plus costly to address all the recurring labs, emergency room visits and h
      NWBO
      TCI1 TCI1 26 minutes ago
      Thanks Captain. Slow and steady, at least the trend is good and compounding will give a value on the UK market. If we could get a bit of a bump in scripts around London/South east area that would help greatly.
      AMRN
      Gusher405 Gusher405 28 minutes ago
      So again for those in the back. That person has been accused by the ‘critics’ as being in management and being Linda. Even though denied constantly here. Proof from the ‘critics’ is posters writing style and big words that are used. If yall have definitive info, prove it. Stop with BS.
      P
      DBMM
      TrendTrade2016 TrendTrade2016 31 minutes ago
      GDHG POST SPLIT MINI MONSTER...RS STOCKS CONTINUE TO BLOW UP
      GDHG
      TheFinalCD TheFinalCD 31 minutes ago
      2nd News https://x.com/Flashalert40064/status/1837053718274978243


      https://www.globenewswire.com/news-release/2024/09/19/2948917/0/en/Banzai-Announces-Reverse-Split-to-Regain-NASDAQ-Compliance.html

      https://finviz.com/quote.ashx?t=BNZI&p=d

      https://d
      BNZI
      knrorrel knrorrel 32 minutes ago
      we need break .50
      imo
      AEMD
      TrendTrade2016 TrendTrade2016 33 minutes ago
      BNZI POST SPLIT MONSTER
      BNZI
      knrorrel knrorrel 33 minutes ago
      nice News Yesterday
      AEMD
      knrorrel knrorrel 34 minutes ago
      AEMD watch
      AEMD
      axelvento axelvento 34 minutes ago
      With Pfizer hitting a stumbling block, Moderna’s COVID-19/influenza vaccine, mRNA-1083, could be the first such combination vaccine to reach the market. In June, the company posted results from a Phase III trial that showed mRNA-1083 produced a strong immune response against both COVID-19 and influe
      MRNA
      Ranb2khz Ranb2khz 37 minutes ago
      Perfectly Loved – Rachael Lampa (feat. TobyMac) [Lyric Video]

      [yt]k1IpEhuq9dU[/yt]

      https://www.youtube.com/watch?v=k1IpEhuq9dU






      •
      ksquared ksquared 39 minutes ago
      And now it's your turn. Happy Birthday, sdheart ! ! !
      Here's to your health and longevity.
      Enjoy the day and many years to come.
      TrendTrade2016 TrendTrade2016 41 minutes ago
      The clown show here is futile, just a couple of dummies believing in the fake news to dump stock… a master class on stupidity and algorithmic manipulation painting a chart. Don’t listen to the clowns.
      ICTY

      Your Recent History

      AMEX
      SYN
      Synthetic Biologics
      Delayed Upgrade Clock